Consequently, TECPR2 might represent a potential candidate gene for late infantile or juvenile cases of NAD in humans that are not associated with a mutation in PLA2G6 and are characterized by the lack of iron accumulations, absence or progressive development of spasticity, visual disturbances and absence of peripheral nerve lesions. The gene discussed is TECPR2; the disease is peripheral nerve lesion.